Logo image of JBSS

JOHN B. SANFILIPPO & SON INC (JBSS) Stock Fundamental Analysis

USA - NASDAQ:JBSS - US8004221078 - Common Stock

64.58 USD
+0.36 (+0.55%)
Last: 9/18/2025, 4:30:02 PM
64.58 USD
0 (0%)
After Hours: 9/18/2025, 4:30:02 PM
Fundamental Rating

4

Overall JBSS gets a fundamental rating of 4 out of 10. We evaluated JBSS against 89 industry peers in the Food Products industry. Both the profitability and the financial health of JBSS get a neutral evaluation. Nothing too spectacular is happening here. JBSS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

JBSS had positive earnings in the past year.
In the past year JBSS had a positive cash flow from operations.
Each year in the past 5 years JBSS has been profitable.
Each year in the past 5 years JBSS had a positive operating cash flow.
JBSS Yearly Net Income VS EBIT VS OCF VS FCFJBSS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

JBSS's Return On Assets of 9.86% is amongst the best of the industry. JBSS outperforms 91.01% of its industry peers.
With an excellent Return On Equity value of 16.34%, JBSS belongs to the best of the industry, outperforming 86.52% of the companies in the same industry.
JBSS has a Return On Invested Capital of 12.81%. This is amongst the best in the industry. JBSS outperforms 91.01% of its industry peers.
The Average Return On Invested Capital over the past 3 years for JBSS is significantly below the industry average of 28.31%.
Industry RankSector Rank
ROA 9.86%
ROE 16.34%
ROIC 12.81%
ROA(3y)12.11%
ROA(5y)13.03%
ROE(3y)18.85%
ROE(5y)20.67%
ROIC(3y)16.04%
ROIC(5y)17.32%
JBSS Yearly ROA, ROE, ROICJBSS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

With a decent Profit Margin value of 5.32%, JBSS is doing good in the industry, outperforming 70.79% of the companies in the same industry.
In the last couple of years the Profit Margin of JBSS has declined.
With a decent Operating Margin value of 7.65%, JBSS is doing good in the industry, outperforming 69.66% of the companies in the same industry.
In the last couple of years the Operating Margin of JBSS has declined.
JBSS's Gross Margin of 18.38% is in line compared to the rest of the industry. JBSS outperforms 47.19% of its industry peers.
In the last couple of years the Gross Margin of JBSS has declined.
Industry RankSector Rank
OM 7.65%
PM (TTM) 5.32%
GM 18.38%
OM growth 3Y-4.93%
OM growth 5Y-3.02%
PM growth 3Y-6.28%
PM growth 5Y-2.84%
GM growth 3Y-4.17%
GM growth 5Y-1.65%
JBSS Yearly Profit, Operating, Gross MarginsJBSS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

4

2. Health

2.1 Basic Checks

JBSS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, JBSS has more shares outstanding
Compared to 5 years ago, JBSS has more shares outstanding
Compared to 1 year ago, JBSS has a worse debt to assets ratio.
JBSS Yearly Shares OutstandingJBSS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
JBSS Yearly Total Debt VS Total AssetsJBSS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

JBSS has an Altman-Z score of 5.12. This indicates that JBSS is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of JBSS (5.12) is better than 87.64% of its industry peers.
JBSS has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.20, JBSS is in the better half of the industry, outperforming 68.54% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Altman-Z 5.12
ROIC/WACC1.51
WACC8.46%
JBSS Yearly LT Debt VS Equity VS FCFJBSS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 2.22 indicates that JBSS has no problem at all paying its short term obligations.
JBSS has a better Current ratio (2.22) than 68.54% of its industry peers.
A Quick Ratio of 0.59 indicates that JBSS may have some problems paying its short term obligations.
The Quick ratio of JBSS (0.59) is worse than 74.16% of its industry peers.
Industry RankSector Rank
Current Ratio 2.22
Quick Ratio 0.59
JBSS Yearly Current Assets VS Current LiabilitesJBSS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1

3. Growth

3.1 Past

JBSS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.52%.
Measured over the past 5 years, JBSS shows a small growth in Earnings Per Share. The EPS has been growing by 1.37% on average per year.
The Revenue has been growing slightly by 3.79% in the past year.
The Revenue has been growing slightly by 4.70% on average over the past years.
EPS 1Y (TTM)-2.52%
EPS 3Y-0.91%
EPS 5Y1.37%
EPS Q2Q%33.72%
Revenue 1Y (TTM)3.79%
Revenue growth 3Y5.02%
Revenue growth 5Y4.7%
Sales Q2Q%-0.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JBSS Yearly Revenue VS EstimatesJBSS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
JBSS Yearly EPS VS EstimatesJBSS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2024 2025 1 2 3 4 5

3

4. Valuation

4.1 Price/Earnings Ratio

JBSS is valuated correctly with a Price/Earnings ratio of 12.84.
Based on the Price/Earnings ratio, JBSS is valued a bit cheaper than the industry average as 74.16% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.41. JBSS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 12.84
Fwd PE N/A
JBSS Price Earnings VS Forward Price EarningsJBSS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

76.40% of the companies in the same industry are more expensive than JBSS, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.83
JBSS Per share dataJBSS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

The decent profitability rating of JBSS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)9.4
EPS Next 2YN/A
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

JBSS has a Yearly Dividend Yield of 1.41%. Purely for dividend investing, there may be better candidates out there.
JBSS's Dividend Yield is comparable with the industry average which is at 5.03.
With a Dividend Yield of 1.41, JBSS pays less dividend than the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.41%

5.2 History

The dividend of JBSS decreases each year by -19.01%.
JBSS has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-19.01%
Div Incr Years0
Div Non Decr Years0
JBSS Yearly Dividends per shareJBSS Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

41.41% of the earnings are spent on dividend by JBSS. This is a bit on the high side, but may be sustainable.
DP41.41%
EPS Next 2YN/A
EPS Next 3YN/A
JBSS Yearly Income VS Free CF VS DividendJBSS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M 80M 100M
JBSS Dividend Payout.JBSS Dividend Payout, showing the Payout Ratio.JBSS Dividend Payout.PayoutRetained Earnings

JOHN B. SANFILIPPO & SON INC

NASDAQ:JBSS (9/18/2025, 4:30:02 PM)

After market: 64.58 0 (0%)

64.58

+0.36 (+0.55%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-20 2025-08-20/amc
Earnings (Next)10-28 2025-10-28
Inst Owners92.72%
Inst Owner Change-6.23%
Ins Owners0.94%
Ins Owner Change-18.13%
Market Cap751.71M
Analysts85.71
Price TargetN/A
Short Float %2.44%
Short Ratio2.42
Dividend
Industry RankSector Rank
Dividend Yield 1.41%
Yearly Dividend2.1
Dividend Growth(5Y)-19.01%
DP41.41%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-19 2025-08-19 (0.6)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 12.84
Fwd PE N/A
P/S 0.68
P/FCF N/A
P/OCF 24.61
P/B 2.08
P/tB 2.18
EV/EBITDA 6.83
EPS(TTM)5.03
EY7.79%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.73
FCFYN/A
OCF(TTM)2.62
OCFY4.06%
SpS95.12
BVpS30.99
TBVpS29.6
PEG (NY)N/A
PEG (5Y)9.4
Profitability
Industry RankSector Rank
ROA 9.86%
ROE 16.34%
ROCE 19.18%
ROIC 12.81%
ROICexc 12.83%
ROICexgc 13.26%
OM 7.65%
PM (TTM) 5.32%
GM 18.38%
FCFM N/A
ROA(3y)12.11%
ROA(5y)13.03%
ROE(3y)18.85%
ROE(5y)20.67%
ROIC(3y)16.04%
ROIC(5y)17.32%
ROICexc(3y)16.09%
ROICexc(5y)17.36%
ROICexgc(3y)16.85%
ROICexgc(5y)18.29%
ROCE(3y)22.35%
ROCE(5y)24.36%
ROICexcg growth 3Y-10.55%
ROICexcg growth 5Y-7.62%
ROICexc growth 3Y-10.04%
ROICexc growth 5Y-6.93%
OM growth 3Y-4.93%
OM growth 5Y-3.02%
PM growth 3Y-6.28%
PM growth 5Y-2.84%
GM growth 3Y-4.17%
GM growth 5Y-1.65%
F-Score2
Asset Turnover1.85
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Debt/EBITDA 0.65
Cap/Depr 188.31%
Cap/Sales 4.58%
Interest Coverage 25.75
Cash Conversion 27.36%
Profit Quality N/A
Current Ratio 2.22
Quick Ratio 0.59
Altman-Z 5.12
F-Score2
WACC8.46%
ROIC/WACC1.51
Cap/Depr(3y)134.82%
Cap/Depr(5y)127.89%
Cap/Sales(3y)3.1%
Cap/Sales(5y)2.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.52%
EPS 3Y-0.91%
EPS 5Y1.37%
EPS Q2Q%33.72%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.79%
Revenue growth 3Y5.02%
Revenue growth 5Y4.7%
Sales Q2Q%-0.18%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2.08%
EBIT growth 3Y-0.15%
EBIT growth 5Y1.53%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-127.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-69.96%
OCF growth 3Y15.94%
OCF growth 5Y-13.64%